Graham Ball
Graham Ball
Chief Scientific Officer Intelligent Omics Ltd
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer …
DM Abd El‐Rehim, G Ball, SE Pinder, E Rakha, C Paish, JFR Robertson, ...
International journal of cancer 116 (3), 340-350, 2005
Effects of β-alanine supplementation on exercise performance: a meta-analysis
RM Hobson, B Saunders, G Ball, RC Harris, C Sale
Amino acids 43, 25-37, 2012
MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancer
AJ Lowery, N Miller, A Devaney, RE McNeill, PA Davoren, C Lemetre, ...
Breast cancer research 11, 1-18, 2009
Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome
SE Elsheikh, AR Green, EA Rakha, DG Powe, RA Ahmed, HM Collins, ...
Cancer research 69 (9), 3802-3809, 2009
An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers
G Ball, S Mian, F Holding, RO Allibone, J Lowe, S Ali, G Li, S McCardle, ...
Bioinformatics 18 (3), 395-404, 2002
Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990–1999
RW Blamey, IO Ellis, SE Pinder, AHS Lee, RD Macmillan, DAL Morgan, ...
European journal of cancer 43 (10), 1548-1555, 2007
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen
HO Habashy, DG Powe, CM Staka, EA Rakha, G Ball, AR Green, ...
Breast cancer research and treatment 119, 283-293, 2010
An introduction to artificial neural networks in bioinformatics—application to complex microarray and mass spectrometry datasets in cancer studies
LJ Lancashire, C Lemetre, GR Ball
Briefings in bioinformatics 10 (3), 315-329, 2009
NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting
RW McGilvray, RA Eagle, NFS Watson, A Al-Attar, G Ball, I Jafferji, ...
Clinical Cancer Research 15 (22), 6993-7002, 2009
Network Inference Analysis Identifies an APRR2-Like Gene Linked to Pigment Accumulation in Tomato and Pepper Fruits
Y Pan, G Bradley, K Pyke, G Ball, C Lu, R Fray, A Marshall, S Jayasuta, ...
Plant Physiology 161 (3), 1476-1485, 2013
ONCOPOOL–a European database for 16,944 cases of breast cancer
RW Blamey, B Hornmark-Stenstam, G Ball, M Blichert-Toft, L Cataliotti, ...
European journal of cancer 46 (1), 56-71, 2010
Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients
S Mian, S Ugurel, E Parkinson, I Schlenzka, I Dryden, L Lancashire, ...
J Clin Oncol 23 (22), 5088-5093, 2005
Delayed disease progression after allogeneic cell vaccination in hormone-resistant prostate cancer and correlation with immunologic variables
A Michael, G Ball, N Quatan, F Wushishi, N Russell, J Whelan, ...
Clinical cancer research 11 (12), 4469-4478, 2005
Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer
EA Rakha, D Soria, AR Green, C Lemetre, DG Powe, CC Nolan, ...
British journal of cancer 110 (7), 1688-1697, 2014
A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences
AM Shaaban, GR Ball, RA Brannan, G Cserni, AD Benedetto, J Dent, ...
Breast cancer research and treatment 133, 949-958, 2012
An international cooperative programme indicates the widespread occurrence of ozone injury on crops
J Benton, J Fuhrer, BS Gimeno, L Skärby, D Palmer-Brown, G Ball, ...
Agriculture, ecosystems & environment 78 (1), 19-30, 2000
A case-controlled study of the oncologic safety of fat grafting
KL Gale, EA Rakha, G Ball, VK Tan, SJ McCulley, RD Macmillan
Plastic and reconstructive surgery 135 (5), 1263-1275, 2015
MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
AR Green, MA Aleskandarany, D Agarwal, S Elsheikh, CC Nolan, ...
British journal of cancer 114 (8), 917-928, 2016
Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer
TMA Abdel-Fatah, R Russell, N Albarakati, DJ Maloney, D Dorjsuren, ...
Molecular oncology 8 (7), 1326-1338, 2014
Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer
AM McDermott, N Miller, D Wall, LM Martyn, G Ball, KJ Sweeney, MJ Kerin
PloS one 9 (1), e87032, 2014
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20